Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls
- PMID: 17366830
- PMCID: PMC1797844
- DOI: 10.1289/ehp.9488
Pilot study of urinary biomarkers of phytoestrogens, phthalates, and phenols in girls
Abstract
Background: Hormonally active environmental agents have been measured among U.S. children using exposure biomarkers in urine. However, little is known about their variation by race, age, sex, and geography, and no data exist for newly developed biomarkers.
Objective: Our goal was to characterize relevant, prevalent exposures for a study of female pubertal development.
Methods: In a pilot study among 90 girls from New York City, New York, Cincinnati, Ohio, and northern California, we measured 25 urinary analytes representing 22 separate agents from three chemical families: phytoestrogens, phthalates, and phenols. Exposures occur chiefly from the diet and from household or personal care products.
Results: Participants represented four racial/ethnic groups (Asian, black, Hispanic, white), with mean age of 7.77 years. Most analytes were detectable in > 94% of samples. The highest median concentrations for individual analytes in each family were for enterolactone (298 microg/L), monoethylphthalate (MEP; 83.2 microg/L), and benzophenone-3 (BP3; 14.7 microg/L). Few or no data have been reported previously for four metabolites: mono(2-ethyl-5-carboxypentyl) phthalate, tridosan, bisphenol A (BPA), and BP3; these were detected in 67-100% of samples with medians of 1.8-53.2 microg/L. After multivariate adjustment, two analytes, enterolactone and BPA, were higher among girls with body mass index < 85th reference percentile than those at or above the 85th percentile. Three phthalate metabolites differed by race/ethnicity [MEP, mono(2-ethylhexyl) phthalate, and mono-3-carboxypropylphthalate].
Conclusions: A wide spectrum of hormonally active exposure biomarkers were detectable and variable among young girls, with high maximal concentrations (> 1,000 microg/L) found for several analytes. They varied by characteristics that may be relevant to development.
References
-
- Fenton SE. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology. 2006;147:S18–S24. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P01 ES009584/ES/NIEHS NIH HHS/United States
- ES/CA012801/ES/NIEHS NIH HHS/United States
- ES012645/ES/NIEHS NIH HHS/United States
- M01 RR000071/RR/NCRR NIH HHS/United States
- K01 ES012645/ES/NIEHS NIH HHS/United States
- P30 ES006096/ES/NIEHS NIH HHS/United States
- ES/CA12770/ES/NIEHS NIH HHS/United States
- CA93447/CA/NCI NIH HHS/United States
- ES/CA012800/ES/NIEHS NIH HHS/United States
- ES009584/ES/NIEHS NIH HHS/United States
- ES/CA012771/ES/NIEHS NIH HHS/United States
- U01 ES019454/ES/NIEHS NIH HHS/United States
- M01-RR-00071/RR/NCRR NIH HHS/United States
- K07 CA093447/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources